IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN) today announced that the Company will present a poster at the American Society of Nephrology's upcoming Kidney Week 2023 Annual Meeting taking place in Philadelphia, PA from November 2-5, 2023. The poster will highlight new data from Eledon's ongoing open-label Phase 1b trial evaluating tegoprubart for the prevention of rejection in kidney transplantation.
Details on the poster presentations are below:
Title: Tegoprubart for the prevention of rejection in ...